Ginkgo Bioworks Holdings Inc. (DNA) Insider Trading

Last 12 months

Insiders sold $3.56M and bought nothing on the open market.

1% of the selling was scheduled in advance under 10b5-1 plans. See remarks Jason R Kelly sold $1.37M on Apr 9, 40% of their stake, outside a plan. The last open-market buy by an executive or director was in May 2024.

Net open-market

−$3.56M

0 buys · 16 sales

Under a 10b5-1 plan

of the value sold

Insiders who bought / sold

0 / 4

executives and directors

Last open-market buy

May 2024

May 15, 2024

Get an email when DNA's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Oct 19	Steven P. Coen See remarks	SoldNo plan	766	$10.14	$8k	1.5%	Form 4
Oct 19	Barry Canton Large holder	SoldNo plan 2 parts	41,172	$10.14 average	$418k	4.8%	Form 4
Oct 19	Reshma P. Shetty See remarks	SoldNo plan 2 parts	41,172	$10.14 average	$418k	4.8%	Form 4
Oct 19	Jason R Kelly See remarks	SoldNo plan	45,682	$10.14	$463k	26%	Form 4
Oct 5	Steven P. Coen See remarks	Sold10b5-1 plan	2,403	$15.00	$36k	4.6%	Form 4
Sep 15	Christian O Henry Director	SoldNo plan	5,000	$7.08	$35k	21%	Form 4
Aug 24	Steven P. Coen See remarks	SoldNo plan	330	$6.98	$2k	0.6%	Form 4
Jul 17	Steven P. Coen See remarks	SoldNo plan	752	$7.90	$6k	1.4%	Form 4
May 22	Steven P. Coen See remarks	SoldNo plan	307	$8.33	$3k	0.6%	Form 4
Apr 17	Steven P. Coen See remarks	SoldNo plan	324	$7.95	$3k	0.6%	Form 4
Apr 13	Steven P. Coen See remarks	SoldNo plan	33,171	$6.41	$213k	40%	Form 4
Apr 10	Barry Canton Large holder	SoldNo plan	124,727	$6.43	$802k	22%	Form 4
Apr 10	Reshma P. Shetty See remarks	SoldNo plan	124,727	$6.43	$802k	22%	Form 4
Apr 8 – 9	Reshma P. Shetty See remarks	SoldNo plan 2 parts	26,271	$6.67 average	$175k	7.2%	Form 4
Apr 8 – 9	Barry Canton Large holder	SoldNo plan 2 parts	26,271	$6.67 average	$175k	7.2%	Form 4
Apr 8 – 9	Jason R Kelly See remarks	SoldNo plan 2 parts	206,782	$6.65 average	$1.37M	40%	Form 4
Mar 16	Steven P. Coen See remarks	SoldNo plan	708	$6.74	$5k	7.2%	Form 4
Jan 20	Steven P. Coen See remarks	SoldNo plan	972	$8.92	$9k	10%	Form 4
Dec 15, 2025	Steven P. Coen See remarks	SoldNo plan	736	$8.89	$7k	8.9%	Form 4
Oct 17, 2025	Steven P. Coen See remarks	SoldNo plan	1,312	$13.65	$18k	16%	Form 4
Oct 1, 2025	Steven P. Coen See remarks	Sold10b5-1 plan	5,609	$15.00	$84k	50%	Form 4
Sep 8, 2025 – Sep 9, 2025	Christian O Henry Director	SoldNo plan 2 parts	20,000	$10.99 average	$220k	45%	Form 4
Aug 22, 2025	Steven P. Coen See remarks	SoldNo plan	310	$12.40	$4k	2.7%	Form 4
Jul 17, 2025	Steven P. Coen See remarks	SoldNo plan	1,084	$9.84	$11k	9.2%	Form 4
May 21, 2025	Steven P. Coen See remarks	SoldNo plan	346	$7.59	$3k	3.6%	Form 4
May 21, 2025	Mark E. Dmytruk See remarks	SoldNo plan	706	$7.59	$5k	1.5%	Form 4
Apr 21, 2025	Steven P. Coen See remarks	SoldNo plan	997	$7.28	$7k	10%	Form 4
Apr 21, 2025	Mark E. Dmytruk See remarks	SoldNo plan	1,244	$7.28	$9k	2.7%	Form 4
Mar 4, 2025	Steven P. Coen See remarks	SoldNo plan	395	$7.73	$3k	4.7%	Form 4
Mar 4, 2025	Mark E. Dmytruk See remarks	SoldNo plan	790	$7.73	$6k	2.2%	Form 4
Feb 4, 2025	Steven P. Coen See remarks	SoldNo plan	367	$13.44	$5k	4.6%	Form 4
Feb 4, 2025	Mark E. Dmytruk See remarks	SoldNo plan	740	$13.44	$10k	2.1%	Form 4
Jan 6, 2025	Steven P. Coen See remarks	SoldNo plan	324	$11.72	$4k	4.3%	Form 4
Jan 6, 2025	Mark E. Dmytruk See remarks	SoldNo plan	645	$11.72	$8k	1.9%	Form 4
Dec 4, 2024	Steven P. Coen See remarks	SoldNo plan	330	$9.64	$3k	4.6%	Form 4
Dec 4, 2024	Mark E. Dmytruk See remarks	SoldNo plan	741	$9.64	$7k	2.2%	Form 4
Nov 4, 2024	Steven P. Coen See remarks	SoldNo plan	333	$7.58	$3k	4.9%	Form 4
Nov 4, 2024	Mark E. Dmytruk See remarks	SoldNo plan	1,322	$7.58	$10k	4.0%	Form 4

Oct 19No plan
Steven P. Coen
See remarks · sold 766 at $10.14
$8k
1.5% of stake
Oct 19No plan
Barry Canton
Large holder · sold 41,172 at avg $10.14
$418k
4.8% of stake
Oct 19No plan
Reshma P. Shetty
See remarks · sold 41,172 at avg $10.14
$418k
4.8% of stake
Oct 19No plan
Jason R Kelly
See remarks · sold 45,682 at $10.14
$463k
26% of stake
Oct 510b5-1 plan
Steven P. Coen
See remarks · sold 2,403 at $15.00
$36k
4.6% of stake
Sep 15No plan
Christian O Henry
Director · sold 5,000 at $7.08
$35k
21% of stake
Aug 24No plan
Steven P. Coen
See remarks · sold 330 at $6.98
$2k
0.6% of stake
Jul 17No plan
Steven P. Coen
See remarks · sold 752 at $7.90
$6k
1.4% of stake
May 22No plan
Steven P. Coen
See remarks · sold 307 at $8.33
$3k
0.6% of stake
Apr 17No plan
Steven P. Coen
See remarks · sold 324 at $7.95
$3k
0.6% of stake
Apr 13No plan
Steven P. Coen
See remarks · sold 33,171 at $6.41
$213k
40% of stake
Apr 10No plan
Barry Canton
Large holder · sold 124,727 at $6.43
$802k
22% of stake
Apr 10No plan
Reshma P. Shetty
See remarks · sold 124,727 at $6.43
$802k
22% of stake
Apr 8 – 9No plan
Reshma P. Shetty
See remarks · sold 26,271 at avg $6.67
$175k
7.2% of stake
Apr 8 – 9No plan
Barry Canton
Large holder · sold 26,271 at avg $6.67
$175k
7.2% of stake
Apr 8 – 9No plan
Jason R Kelly
See remarks · sold 206,782 at avg $6.65
$1.37M
40% of stake
Mar 16No plan
Steven P. Coen
See remarks · sold 708 at $6.74
$5k
7.2% of stake
Jan 20No plan
Steven P. Coen
See remarks · sold 972 at $8.92
$9k
10% of stake
Dec 15, 2025No plan
Steven P. Coen
See remarks · sold 736 at $8.89
$7k
8.9% of stake
Oct 17, 2025No plan
Steven P. Coen
See remarks · sold 1,312 at $13.65
$18k
16% of stake
Oct 1, 202510b5-1 plan
Steven P. Coen
See remarks · sold 5,609 at $15.00
$84k
50% of stake
Sep 8, 2025 – Sep 9, 2025No plan
Christian O Henry
Director · sold 20,000 at avg $10.99
$220k
45% of stake
Aug 22, 2025No plan
Steven P. Coen
See remarks · sold 310 at $12.40
$4k
2.7% of stake
Jul 17, 2025No plan
Steven P. Coen
See remarks · sold 1,084 at $9.84
$11k
9.2% of stake
May 21, 2025No plan
Steven P. Coen
See remarks · sold 346 at $7.59
$3k
3.6% of stake
May 21, 2025No plan
Mark E. Dmytruk
See remarks · sold 706 at $7.59
$5k
1.5% of stake
Apr 21, 2025No plan
Steven P. Coen
See remarks · sold 997 at $7.28
$7k
10% of stake
Apr 21, 2025No plan
Mark E. Dmytruk
See remarks · sold 1,244 at $7.28
$9k
2.7% of stake
Mar 4, 2025No plan
Steven P. Coen
See remarks · sold 395 at $7.73
$3k
4.7% of stake
Mar 4, 2025No plan
Mark E. Dmytruk
See remarks · sold 790 at $7.73
$6k
2.2% of stake
Feb 4, 2025No plan
Steven P. Coen
See remarks · sold 367 at $13.44
$5k
4.6% of stake
Feb 4, 2025No plan
Mark E. Dmytruk
See remarks · sold 740 at $13.44
$10k
2.1% of stake
Jan 6, 2025No plan
Steven P. Coen
See remarks · sold 324 at $11.72
$4k
4.3% of stake
Jan 6, 2025No plan
Mark E. Dmytruk
See remarks · sold 645 at $11.72
$8k
1.9% of stake
Dec 4, 2024No plan
Steven P. Coen
See remarks · sold 330 at $9.64
$3k
4.6% of stake
Dec 4, 2024No plan
Mark E. Dmytruk
See remarks · sold 741 at $9.64
$7k
2.2% of stake
Nov 4, 2024No plan
Steven P. Coen
See remarks · sold 333 at $7.58
$3k
4.9% of stake
Nov 4, 2024No plan
Mark E. Dmytruk
See remarks · sold 1,322 at $7.58
$10k
4.0% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch DNA, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Related stocks: Biological Products, (No Diagnostic Substances)

AGENAgenus Inc.

AUTLAutolus Therapeutics plc

IPSCCentury Therapeutics, Inc.

BEAMBeam Therapeutics Inc.

KYMRKymera Therapeutics Inc.

IBRXImmunityBio, Inc.

FDMT4D Molecular Therapeutics, Inc.

RGNXRegenxbio Inc.

Spot a number that looks wrong? Check it in DNA's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing DNA

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.